Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felicita Andreotti

Showing results (191-200 of 236) with videos related to

Pageof 24
Sort By:
Minerva Cardiology and Angiology|February 15, 2022
Oral anticoagulants in fragile patients with percutaneous endoscopic gastrostomy and atrial fibrillation: the ORIGAMI pilot investigationDomenico D'Amario, Mattia Galli, Luigi Cappannoli, et al.
European Heart Journal|May 19, 2026
Aspirin vs clopidogrel in chronic coronary syndromes: a meta-analysis of ethnic differencesClaudio Laudani, Giovanni Occhipinti, Francesco Costa, et al.
International Journal of Cardiology|May 17, 2021
Results of an international crowdsourcing survey on the treatment of non-ST segment elevation ACS patients at high-bleeding risk undergoing percutaneous interventionDeepak L Bhatt, Juan Carlos Kaski, Sean Delaney, et al.
Thrombosis and Haemostasis|November 15, 2013
Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart DiseaseRaffaele De Caterina, Steen Husted, Lars Wallentin, et al.
Journal of the American College of Cardiology|April 14, 2012
New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paperRaffaele De Caterina, Steen Husted, Lars Wallentin, et al.
Minerva Cardiology and Angiology|April 7, 2021
Intracoronary bolus of glycoprotein IIb/IIIa inhibitor as bridging or adjunctive strategy to oral P2Y12 inhibitor load in the modern setting of ST-elevation myocardial infarctionMattia Galli, Stefano Migliaro, Daniele Rodolico, et al.
European Heart Journal|December 8, 2022
Acute, periprocedural and longterm antithrombotic therapy in older adults: 2022 Update by the ESC Working Group on ThrombosisFelicita Andreotti, Tobias Geisler, Jean-Philippe Collet, et al.
Thrombosis and Haemostasis|March 1, 2013
General mechanisms of coagulation and targets of anticoagulants (Section I). Position Paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart DiseaseRaffaele De Caterina, Steen Husted, Lars Wallentin, et al.
Journal of Clinical Medicine|October 16, 2024
Acute Coronary Syndrome in Elderly Patients: How to Tackle Them?Fabiana Lucà, Felicita Andreotti, Carmelo Massimiliano Rao, et al.
Revista Espanola De Cardiologia (English Ed.)|December 18, 2015
2015 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-segment ElevationMarco Roffi, Carlo Patrono, Jean-Philippe Collet, et al.
Pageof 24

Showing results (191-200 of 236) with videos related to

Sort By:
Pageof 24
Minerva Cardiology and Angiology|February 15, 2022
Oral anticoagulants in fragile patients with percutaneous endoscopic gastrostomy and atrial fibrillation: the ORIGAMI pilot investigationDomenico D'Amario, Mattia Galli, Luigi Cappannoli, et al.
European Heart Journal|May 19, 2026
Aspirin vs clopidogrel in chronic coronary syndromes: a meta-analysis of ethnic differencesClaudio Laudani, Giovanni Occhipinti, Francesco Costa, et al.
International Journal of Cardiology|May 17, 2021
Results of an international crowdsourcing survey on the treatment of non-ST segment elevation ACS patients at high-bleeding risk undergoing percutaneous interventionDeepak L Bhatt, Juan Carlos Kaski, Sean Delaney, et al.
Thrombosis and Haemostasis|November 15, 2013
Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart DiseaseRaffaele De Caterina, Steen Husted, Lars Wallentin, et al.
Journal of the American College of Cardiology|April 14, 2012
New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paperRaffaele De Caterina, Steen Husted, Lars Wallentin, et al.
Minerva Cardiology and Angiology|April 7, 2021
Intracoronary bolus of glycoprotein IIb/IIIa inhibitor as bridging or adjunctive strategy to oral P2Y12 inhibitor load in the modern setting of ST-elevation myocardial infarctionMattia Galli, Stefano Migliaro, Daniele Rodolico, et al.
European Heart Journal|December 8, 2022
Acute, periprocedural and longterm antithrombotic therapy in older adults: 2022 Update by the ESC Working Group on ThrombosisFelicita Andreotti, Tobias Geisler, Jean-Philippe Collet, et al.
Thrombosis and Haemostasis|March 1, 2013
General mechanisms of coagulation and targets of anticoagulants (Section I). Position Paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart DiseaseRaffaele De Caterina, Steen Husted, Lars Wallentin, et al.
Journal of Clinical Medicine|October 16, 2024
Acute Coronary Syndrome in Elderly Patients: How to Tackle Them?Fabiana Lucà, Felicita Andreotti, Carmelo Massimiliano Rao, et al.
Revista Espanola De Cardiologia (English Ed.)|December 18, 2015
2015 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-segment ElevationMarco Roffi, Carlo Patrono, Jean-Philippe Collet, et al.
Pageof 24